Recombinant MAPT (Semorinemab Biosimilar) 抗体
This Humanized Chimeric antibody specifically detects MAPT (Semorinemab Biosimilar) in ELISA 和 WB. It exhibits reactivity toward 人.
产品编号 ABIN7538081
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MAPT (Semorinemab Biosimilar) 抗体 (ABIN7538081)
抗原
MAPT (Semorinemab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This MAPT (Semorinemab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Semorinemab Biosimilar - Anti-MAPT mAb - Research Grade
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG4
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- MAPT (Semorinemab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Semorinemab (RG 6100) is an anti-Tau humanized IgG4 monoclonal antibody, targets the N-terminal portion of the Tau protein (amino acid residues 6-23). Semorinemab binds with human Tau with a Kd value of 3.8 nM. Semorinemab can be used for the research of Alzheimer's Disease.
-
CAS-编号
- 2159141-27-0
抗原
-
You are here:
